enVVeno Medical CorporationNVNONASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +43.06% | +53.03% | +26.75% | +26.67% | +25.44% |
| Weighted Average Shares Diluted Growth | +43.06% | +53.03% | +26.75% | +26.67% | +25.44% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +79.36% | -7.57% | -9.48% | -10.78% | -35.80% |
| Book Value per Share Growth | +32.90% | -40.37% | -28.67% | -32.07% | -50.44% |
| Debt Growth | -22.38% | -24.11% | -25.66% | -28.47% | -31.10% |
| R&D Expense Growth | +2.18% | +17.85% | -16.22% | +2.34% | -9.58% |
| SG&A Expenses Growth | +31.87% | -3.13% | -1.52% | +61.57% | -31.55% |